News Releases
- Chugai Obtains Regulatory Approval for “LUNSUMIO for Intravenous Infusion” for Relapsed or Refractory Follicular Lymphoma in Japan
- Chugai Received Second Rating in Pharmaceutical Sector in the “DJSI World,” a Global ESG Investment Index
- Galderma’s Announcement Regarding Nemolizumab (CHMP Positive Opinion for the Treatment of Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis)
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary